Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06673381

High Sensitive C-reactive Protein to Albumin Ratio in Acute Coronary Syndrome

Prediction of Acute Coronary Syndrome In-hospital Major Adverse Cardiovascular Events by High Sensitivity C- Reactive Protein to Albumin Ratio

Status
Recruiting
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients

Detailed description

Observational study conducted at coronary care unit(CCU) in sohag university hospital It included patients with ACS diagnosed according to AHA/ACCF guidelines (according to symptoms, ECG findings and serum troponin levels), who had admitted to the CCU. Venous blood samples were instantly collected on admission to the hospital. hs-CRP , serum albumin level were measured. hs-CAR is calculated and the patients divided into two groups: Group A ( patients with high hs-CAR) and group B ( patients with low hs-CAR) In-hospital MACE was regarded as the end point of our study. It was defined as acute heart failure, cardiogenic shock, reinfarction, all-cause death, serious arrhythmia and cardiac death

Conditions

Timeline

Start date
2024-11-01
Primary completion
2024-11-01
Completion
2025-10-01
First posted
2024-11-04
Last updated
2024-11-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06673381. Inclusion in this directory is not an endorsement.